Cortico-Subcortical Dynamics in Parkinson's Disease /
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2009.
|
| Edition: | 1st ed. 2009. |
| Series: | Contemporary Neuroscience
|
| Subjects: |
Table of Contents:
- Cortico-Subcortical Circuits and Parkinson's Disease
- Leading Toward a Unified Cortico-basal Ganglia Functional Model
- Modeling Parkinson's Disease: 50 Years Later
- Physiological Studies of the Cortico-subcortical Dynamics and Parkinson's Disease
- Phasic Dopaminergic Signaling: Implications for Parkinson's Disease
- Striatal Dendritic Adaptations in Parkinson's Disease Models
- Diversity of Up-State Voltage Transitions During Different Network States
- The Corticostriatal Pathway in Parkinson's Disease
- Cholinergic Interneuron and Parkinsonism
- Basal Ganglia Network Synchronization in Animal Models of Parkinson's Disease
- Converging into a Unified Model of Parkinson's Disease Pathophysiology
- The Corticostriatal Transmission in Parkinsonian Animals: In Vivo Studies
- Striatal Nitric Oxide-cGMP Signaling in an Animal Model of Parkinson's Disease
- Dopamine-Endocannabinoid Interactions in Parkinson's Disease
- Glutamate Plasticity in an Animal Model of Parkinson's Disease
- Computational Analyses of the Cortico-Subcortical Dynamics and Parkinson's Disease
- Neuromodulation and Neurodynamics of Striatal Inhibitory Networks: Implications for Parkinson's Disease
- Dopaminergic Modulation of Corticostriatal Interactions and Implications for Parkinson's Disease
- Neurobiology and Pathophysiology of Parkinson's Disease
- Pathogenesis of Oxidative Stress and the Destructive Cycle in the Substantia Nigra in Parkinson's Disease
- Regulation of G-Protein-Coupled Receptor (GPCR) Trafficking in the Striatum in Parkinson's Disease
- Atypical Parkinsonism in the French West Indies: The Plant Toxin Annonacin as a Potential Etiological Factor
- Cognitive Deficits in Parkinson's Disease
- Pharmacological and Non-Pharmacological Treatments in Parkinson's Disease
- Dopamine Replacement Therapy in Parkinson's Disease: Past, Present and Future
- Molecular, Cellular and Electrophysiological Changes Triggered by High-Frequency Stimulation of the Subthalamic Nucleus in Animal Models of Parkinson's Disease
- Surgical Strategies for Parkinson's Disease Based on Animal Model Data: GPi and STN Inactivation on Various Aspects of Behavior (Motor, Cognitive and Motivational Processes)
- Antidromic Cortical Activity as the Source of Therapeutic Actions of Deep Brain Stimulation
- Cell-Based Replacement Therapies for Parkinson's Disease.